A Pilot Study to Determine the Feasibility of Conducting a Randomized Clinical Trial Comparing Fondaparinux Sodium (Arixtra) Once Daily With Enoxaparin (Lovenox) Twice Daily With Respect to Preventing VTE After Bariatric Surgery
Phase of Trial: Phase 0
Latest Information Update: 19 Aug 2014
At a glance
- Drugs Enoxaparin sodium (Primary) ; Fondaparinux sodium (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Thromboembolism
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 06 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Jun 2013 Planned end date changed from 1 Jun 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.